SOPH - SOPHiA GENETICS S.A. Stock Analysis | Stock Taper
Logo

About SOPHiA GENETICS S.A.

https://www.sophiagenetics.com

SOPHiA GENETICS SA operates as a healthcare technology company. The company offers SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, products, and services are used by hospital, laboratory, and biopharma worldwide.

Jurgi Camblong

CEO

Jurgi Camblong

Compensation Summary
(Year )

Total Compensation (Unknown At The Moment)
Industry Medical - Healthcare Information Services
Sector Healthcare
Went public July 23, 2021
Method of going public IPO
Full time employees 423

ETFs Holding This Stock

Summary

Total 1

Showing Top 1 of 1

Ratings Snapshot

Rating : D+

Discounted Cash Flow 1
Return On Equity 1
Return On Assets 1
Debt To Equity 1
Price To Earnings 1
Price To Book 2
Overall Score 1

Most Recent Analyst Grades

Grade Summary

Buy 1

Showing Top 1 of 1

Price Target

Target High $6
Target Low $5
Target Median $5
Target Consensus $5.33

Institutional Ownership